2007
DOI: 10.1002/bjs.5945
|View full text |Cite
|
Sign up to set email alerts
|

Randomized clinical trial of the effect of adding subfascial endoscopic perforator surgery to standard great saphenous vein stripping

Abstract: ISRCTN18288048 (http://www.controlled-trials.com).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
35
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 55 publications
(36 citation statements)
references
References 24 publications
(32 reference statements)
1
35
0
Order By: Relevance
“…23,[342][343][344][346][347][348]350 Therapy can be repeated with ease, risk of complications is minimal, and early to midterm results in case series are equivalent to or better than those reported after conventional perforating vein interruptions. [356][357][358] The risks of open procedures, which specifically include infection, difficulty in healing of incisions required for treatment, increased local trauma, and need for general anesthesia, set open operations apart from these less invasive percutaneous methods.…”
Section: Evidence -C]mentioning
confidence: 49%
See 1 more Smart Citation
“…23,[342][343][344][346][347][348]350 Therapy can be repeated with ease, risk of complications is minimal, and early to midterm results in case series are equivalent to or better than those reported after conventional perforating vein interruptions. [356][357][358] The risks of open procedures, which specifically include infection, difficulty in healing of incisions required for treatment, increased local trauma, and need for general anesthesia, set open operations apart from these less invasive percutaneous methods.…”
Section: Evidence -C]mentioning
confidence: 49%
“…[339][340][341][342][343][344][345][346][347][348][349][350][351][352] The Dutch RCT comparing subfascial endoscopic perforator vein surgery (SEPS) with or without superficial reflux ablation to medical treatment in patients with venous ulcers found no difference in healing rate or recurrence in the two treatment groups. 317 However, patients with recurrent ulceration or medially located ulcers in the surgical group had a longer ulcer-free period than did those treated in the conservative group (P ¼ .02).…”
Section: Guideline 61 Superficial Venous Reflux and Active Venous Lementioning
confidence: 99%
“…Current data do not support adding perforator ablation to ablation of the superficial system in patients with simple varicose veins, 361,362 and the Committee recommends against treatment of perforators in patients with CEAP class C 2 disease (GRADE 1B). In patients with advanced CVI, current data provide moderate evidence that large (Ն3.5 mm), high-volume, incompetent "pathologic" perforators (reflux Ն500 ms), located in the affected area of the limb with outward flow on duplex scanning in patients with class C 5 or C 6 disease, can be treated by experienced interventionists, unless the deep veins are obstructed (GRADE 2B).…”
Section: Results Of Perforator Ablationmentioning
confidence: 96%
“…Recommendations from the American Venous Forum and Society of Vascular Surgery (7) limit indications of perforator ablation to those in close proximity to venous stasis ulcers in patients with advanced (C5/C6) disease. Studies examining perforator vein interruption at earlier disease stages were based on highly invasive surgical treatments that overshadowed any improvement in patient quality of life (16,17). The minimally invasive nature of endothermal modalities overcomes the high morbidity of traditional surgical techniques such as subendoscopic perforator surgery (18,19), and establishing the technical feasibility and safety of perforating vein EVLA sets the stage for larger-scale studies aimed at revising treatment indications.…”
Section: Discussionmentioning
confidence: 99%